The global fluorescence in situ hybridization imaging systems market size is expected to reach USD 1.4 billion by 2025, at a CAGR of 8.1% according to a new report by Grand View Research, Inc. Increasing R&D investments pertaining to in vitro diagnostics are expected to drive the Fluorescence In Situ Hybridization (FISH) imaging systems market. The presence of government organizations, such as the European Diagnostic Manufacturers Association that focuses on the development and growth of the in vitro diagnostics market in Europe, is also contributing to growth.
Furthermore, FISH imaging systems are gaining popularity in diagnostics for the determination of suspected diseases caused by pathogens or bacteria. Increasing incidence of genetic diseases, such as lymphoma, solid tumors, leukemia, autism, and other developmental syndromes, is also expected to boost adoption. Growing penetration of fluoroscopy, microscopes, illuminators, and CCD cameras in testing for infectious diseases is expanding growth opportunities for these systems. Increasing prevalence of diseases with chromosomal aberrations, such as cancer and genetic abnormalities, as well as unmet diagnostic & clinical needs in developing countries, is anticipated to drive the market.
Moreover, increasing demand for rapid, sensitive, & accurate diagnostic techniques for validation of diseases, coupled with rising awareness, increase in healthcare expenditure, and extensive R&D for the development of novel imaging systems are also expected to drive growth over the forecast period.
To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/fluorescence-in-situ-hybridization-fish-imaging-systems-market
Further Key Findings From the Report Suggest:
Instruments held the largest market, whereas FISH imaging services are expected to grow at the fastest rate during the forecast period
At present, the market penetration of FISH imaging in cancer diagnostics is very high, hence the diagnostic laboratories segment accounted for larger revenues
Cancer diagnosis held the largest revenue share owing to increasing incidence of cancer, thus fueling the adoption of FISH imaging systems
Among end-use segments, companion diagnostics is expected to witness faster growth than research and diagnostic segments
Diagnostic laboratories held the dominant position in 2016 as these systems are predominantly used in various clinical studies for visualization of precancerous lesions in cervical cancer, assessing the risk of human papillomavirus, and for detection of leukemia, myelodysplastic syndrome, multiple myeloma, & chromosomal abnormalities
North America held the largest revenue share owing to extensive adoption of these solutions in research and development across this region
Asia Pacific is anticipated to exhibit lucrative CAGR over the forecast period due to the increase in investments by manufacturers & governments, supportive government initiatives in the biotechnology sector, and the presence of a large number of untapped opportunities
The industry is highly competitive with a limited number of players holding a majority of the overall revenues. Some of the most notable market participants are Thermo Fisher Scientific, Inc., and General Electric Company. They account for a considerable share of the industry
Grand View Research has segmented the global FISH imaging systems market on the basis of product, application, end use, and region:
FISH Imaging Systems Product Outlook (Revenue, USD Million, 2014 - 2025)
Instruments
Microscopes
Automated cell analyzers
Others
Consumables & Accessories
Services
Software
FISH Imaging Systems Application Outlook (Revenue, USD Million, 2014 - 2025)
Cancer Diagnosis
Lung cancer
Breast cancer
Others
Genetic Disease Diagnosis
Others
FISH Imaging Systems End-use Outlook (Revenue, USD Million, 2014 - 2025)
Diagnostic Laboratories
Research & Academic Institutes
Others
FISH Imaging Systems Regional Outlook (Revenue, USD Million, 2014 - 2025)
North America
The U.S.
Canada
Europe
The U.K.
Germany
France
Italy
Spain
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
The Middle East & Africa
South Africa
Saudi Arabia
"The quality of research they have done for us has been excellent..."